TP Strategic Partner: Using his model, it is easy to understand why companies like $GSK $VRX $MRK $NVS deserve to trade at 25X multiples. They are the financiers
5 hours and 4 minutes ago
TradeTherapAnalytics: anyone with a fundamentally different view than $GSK of the rest of the pipeline on $IONS ..
15 hours and 6 minutes ago
BioPharma Dive: ICYMI: Fate of $IONS drug in doubt after $GSK decides against Phase 3 study
15 hours and 13 minutes ago